CCM
CDNA icon

Coldstream Capital Management’s CareDx CDNA Stock Holding History

Coldstream Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-195
Closed -$3.46K – 1506
2025
Q1 		$3.46K Buy
+195
New +$4.2K ﹤0.01% 2837

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Coldstream Capital Management's CDNA Position: Q2 2025 in Review

Coldstream Capital Management sold out of CareDx (CDNA) in Q2 2025, closing a stake of 195 shares — an estimated $3.46K sold.

Coldstream Capital Management first reported a position in CDNA in Q1 2025 and held it in 1 quarter. The position peaked at $3.46K in Q1 2025. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Coldstream Capital Management reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 195 CareDx shares in Q2 2025, an estimated $3.46K.
  • Coldstream Capital Management first reported a position in CareDx in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's CareDx position peaked at $3.46K in Q1 2025.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.